Skip to main content
    C

    Cosmos Health Inc. (COSM)

    Official site

    HEALTHCARE • MEDICAL DISTRIBUTION • NASDAQ

    $2.49
    -0.75 (-23.15%)

    Market Cap: $16.30M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Cosmos Health Inc. (COSM) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Cosmos Health (COSM) trades at 2.0x sales and 7.2x book value. Its P/B of 7.2x is below its 5-year median of 172.6x. Its forward P/E is 2.3x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E2.3x
    Price to sales2.0x
    Price to book7.2x
    PEGN/A
    FCF yield-7.7%
    As of Nov 17, 2026

    Historical Medians

    MultipleCurrent5-year median10-year median
    P/B7.2x172.6xN/A
    Medians of month-end values through Oct 2026: 50 months (5-year).

    Valuation History

    Over the 4 of the 10 year ends shown that have a P/S, its P/S ranged from 17.8x in 2025 to 675.2x in 2016. 2025 was the lowest of those years.

    Year endPriceP/SP/B
    2025$199.2017.8x22.2x
    2024$267.6082.8x140.9x
    2023$564.00130.5x248.7x
    2022$1,824.00N/A194.9x
    2021$33,700.00N/AN/A
    2020$51,000.00N/AN/A
    2019$22,000.00N/AN/A
    2018$40,000.00N/AN/A
    2017$102,000.00N/AN/A
    2016$8,200.00675.2xN/A
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported.

    GNG Valuation

    GNG viewOvervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About COSM

    What is COSM's forward P/E ratio?

    Cosmos Health has a forward P/E ratio of 2.3x.

    Is COSM stock overvalued?

    GNG's valuation label for COSM is Overvalued.

    What is COSM's price to sales ratio?

    Cosmos Health has a price to sales ratio of 2.0x.